<!DOCTYPE html>
<!-- paulirish.com/2008/conditional-stylesheets-vs-css-hacks-answer-neither/
-->
<!--[if lt IE 7]>
<html class="no-js lt-ie9 lt-ie8 lt-ie7" lang="en">
<![endif]-->
<!--[if IE 7]>
<html class="no-js lt-ie9 lt-ie8" lang="en">
<![endif]-->
<!--[if IE 8]>
<html class="no-js lt-ie9" lang="en">
<![endif]-->
<!--[if gt IE 8]>
<!-->
<html class="no-js" lang="en">
<!--<![endif]-->

<head>
    <meta charset="utf-8" />
    <!-- Set the viewport width to device width for mobile -->
    <meta name="viewport" content="width=device-width" />
    <title>
        PracticeUpdate : Expert Opinion Item
    </title>
    <link rel="stylesheet" href="assets/css/app.css">
    <link rel="stylesheet" href="assets/css/font-awesome.css">
    <link rel="stylesheet" href="assets/css/fc-webicons.css">
    <link rel="stylesheet" href="assets/css/foundation-icons-general.css">
    <script src="assets/js/foundation/modernizr.foundation.js">
    </script>
    <!-- IE Fix for HTML5 Tags -->
    <!--[if lt IE 9]>
        <script src="http://html5shiv.googlecode.com/svn/trunk/html5.js">
        </script>
    <![endif]-->
</head>

<body id="page" class="update off-canvas slide-nav expert-opinion-item logged-out">
    <div class="widget ad">
        <div id="leaderboard" class="Breast ad-container">
            <div class="ad-title">
                <span class="ad-title-text">
                    advertisement
                </span>
            </div>
            <!--/.ad-title-->
            <div id="leaderboardcontent" class="ad-content">
            </div>
            <!--.ad-content-->
        </div>
        <!--/#leaderboard.ad-container-->
    </div>
    <!--/.widget.ad-->
    <div class="page-header">
    </div>
    <!--/.page-header-->
    <div class="page-content">
        <section role="main">
            <div class="single-item-container">
                <article class="type-expert-opinion single-item">
                    <!-- info taken from: http://oncologystat.com/viewpoints/seminal_articles/Seminal_Articles_Germ_Cell_Tumors.html
                    -->
                    <div class="item-header-container">
                        <header class="item-header">
                            <div class="flag-container">
                                <span class="flag featured">
                                    <i class="icon-bolt">
                                    </i>
                                    featured
                                </span>
                                <span class="flag story-of-the-week">
                                    <i class="icon-bolt">
                                    </i>
                                    story of the week
                                </span>
                            </div>
                            <div class="meta pub-meta">
                                <span class="item-type">
                                    Seminal Article
                                </span>
                                <span class="item-pub-date">
                                    <time datetime="12-12-19">
                                        December 19, 2012
                                </span>
                            </div>
                            <hgroup class="item-title-container">
                                <h1 class="item-title">
                                    Seminal Articles—Pancreatic Cancer
                                </h1>
                                <p class="item-citation">
                                    <!-- {{source.citation}} -->
                                    2012 Apr 26, Philip A. Philip, MD, PhD, FRCP, Editor: Matthew Eadens, MD
                                </p>
                            </hgroup>
                            <!-- /.item-title-container -->
                        </header>
                    </div>
                    <!--/.item-header-container-->
                    <div class="item-content-container">
                        <div class="item-content">
                            <div class="item-content-section">
                                <section class="seminal-article-body">
                                    <div class="seminal-article-body-container">
                                        <div class="source-container">
                                            <div class="vcard">
                                            </div>
                                            <!--/.vcard-->
                                        </div>
                                        <!--/.source-container-->
                                        <p>Based on our expert’s review, here are the must-read articles for every oncologist about&nbsp;patients with&nbsp;pancreatic cancer.

</p><p><strong>Epidemiology, genetics</strong></p><p>Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. <a target="_blank" href="http://pdn.sciencedirect.com/science?_ob=MiamiImageURL&amp;_cid=272484&amp;_user=8071087&amp;_pii=S152169180500154X&amp;_check=y&amp;_origin=search&amp;_zone=rslt_list_item&amp;_coverDate=2006-04-30&amp;wchp=dGLzVlV-zSkWA&amp;md5=04d4c74fca51d98b820dbc2f6455d033/1-s2.0-S152169180500154X-main.pdf">Best Pract Res Clin Gastroenterol. 2006; 20:197-209</a>. Elsevier</p><p>Delpu Y, Hanoun N, Lulka H, et al. Genetic and epigenetic alterations in pancreatic carcinogenesis. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129039/?tool=pubmed">Curr Genomics. 2011; 12:15-24</a>. <strong>Free</strong></p><p><strong>Supportive management</strong></p><p>van der Gaag NA, Rauws EA, van Eijck CH, et al. Preoperative biliary drainage for cancer of the head of the pancreas. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa0903230">N Engl J Med. 2010; 362:129-37</a>. <strong>Free</strong></p><p><strong>Tumor markers</strong></p><p>Hess V, Glimelius B, Dietrich D, et al. CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomized controlled trial. <a target="_blank" href="http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(08)70001-9/abstract">Lancet Oncol. 2008; 9(2): 132-138</a>.</p><p>Berger AC, Garcia M Jr, Hoffman JP, et al. Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. <a target="_blank" href="http://jco.ascopubs.org/content/26/36/5918.long">J Clin Oncol. 2008; 26(36): 5918-5922</a>.</p><p><strong>Molecular Markers</strong></p><p>Farrell JJ, Elsaleh H, Garcia M, et al. Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. <a target="_blank" href="http://www.gastrojournal.org/article/S0016-5085(08)01734-4/abstract?referrer=http://www.ncbi.nlm.nih.gov/pubmed/18992248">Gastroenterology.2009 Jan;136(1):187-95</a>. Elsevier</p><p>DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668706/?tool=pubmed">J Clin Oncol. 2010 April. 27(11):1806-13</a>. <strong>Free</strong></p><p><strong>Adjuvant treatment</strong></p><p>Kalser MH, Ellenberg SS: Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. <a target="_blank" href="http://archsurg.ama-assn.org/cgi/reprint/120/8/899">Arch Surg. 1985; 120:899-903</a>.</p><p>Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1420941/?tool=pubmed">Ann Surg. 1999; 230:776-782</a>. <strong>Free</strong></p><p>Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa032295">N Engl J Med. 2004; 350:1200-1210</a>. <strong>Free</strong></p><p>Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. <a target="_blank" href="http://jama.ama-assn.org/content/304/10/1073.long">JAMA. 2010; 304:1073-81</a>.</p><p>Neuhaus P, Riess H, Post S, et al. CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC). <a target="_blank" href="http://meeting.ascopubs.org/cgi/content/abstract/26/15_suppl/LBA4504">J Clin Oncol (Meeting Abstracts) 2008; 26:LBA4504</a>. <strong>Free</strong></p><p>Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. <a target="_blank" href="http://jama.ama-assn.org/content/297/3/267">JAMA. 2007; 297:267-277</a>. <strong>Free</strong></p><p>Regine WF, Winter KA, Abrams RA, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. <a target="_blank" href="http://jama.ama-assn.org/content/299/9/1019.long">JAMA. 2008; 299:1019-1026</a>.</p><p>Regine WF, Winter KA, Abrams RA, et al. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. <a target="_blank" href="http://www.springerlink.com/content/h2747pn3278117n3/fulltext.html">Ann Surg Oncol. 2011; 18(5): 1319-1326</a>.</p><p><strong>Neoadjuvant/preoperative treatment</strong></p><p>Massucco P, Capussotti L, Magnino A, et al. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. <a target="_blank" href="http://www.springerlink.com/content/y3j5854855815565/fulltext.html">Ann Surg Oncol. 2006; 13(9): 1201-1208</a>.</p><p>Breslin TM, Hess KR, Harbison DB, et al. Neoadjuvant chemotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. <a target="_blank" href="http://www.springerlink.com/content/37c92jm1uql0kvfr/fulltext.pdf">Ann Surg Oncol. 2001; 8(2): 123-132</a>.</p><p>Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. <a target="_blank" href="http://jco.ascopubs.org/content/26/21/3496.long">J Clin Oncol. 2008; 26:3496-3502</a>.</p><p>Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S1072751507019813">J Am Coll Surg. 2008; 206:833-846</a>. Elsevier</p><p><strong>Locally advanced/metastatic disease treatment</strong></p><p>Burris HA, 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. <a target="_blank" href="http://jco.ascopubs.org/content/15/6/2403.long">J Clin Oncol. 1997; 15:2403-2413</a>.</p><p>Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. <a target="_blank" href="http://jco.ascopubs.org/content/25/15/1960.long">J Clin Oncol. 2007; 25:1960-6</a>.</p><p>Loehrer PJ, Sr., Feng Y, Cardenes H, et al. Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial. <a target="_blank" href="http://jco.ascopubs.org/content/29/31/4105.long">J Clin Oncol. 2011; 29(31): 4105-4112</a>.</p><p>Cunningham D, Chau I, Stocken DD, et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. <a target="_blank" href="http://www.jco.org/cgi/pmidlookup?view=long&amp;pmid=19858379">J Clin Oncol. 2099; 27:5513-5518</a>.</p><p>Heinemann V, Boeck S, Hinke A, et al. Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer. <a target="_blank" href="http://www.biomedcentral.com/1471-2407/8/82">BMC Cancer. 2008; 8:82</a>.</p><p>Kindler HL, Niedzwiecki D, Hollis D, et al: Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). <a target="_blank" href="http://jco.ascopubs.org/content/28/22/3617.long">J Clin Oncol. 2010; 28:3617-3622</a>.</p><p>Philip PA, Benedetti J, Corless CL, et al. Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. <a target="_blank" href="http://jco.ascopubs.org/content/28/22/3605.long">J Clin Oncol. 2010; 28:3605-3610</a>.</p><p>Van Cutsem E, Vervenne WL, Bennouna J, et al. Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. <a target="_blank" href="http://jco.ascopubs.org/content/27/13/2231.long">J Clin Oncol. 2009; 27:2231-2237</a>.</p><p>Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa1011923">N Engl J Med. 2011; 364:1817-1825</a>. <strong>Free</strong></p><p>Philip PA, Mooney M, Jaffe D, et al. Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment. <a target="_blank" href="http://jco.ascopubs.org/content/27/33/5660.long">J Clin Oncol. 2009 Nov 20;27(33):5660-9</a>.</p><p>Von Hoff DD, Ramanathan RK, Borad MJ, et al. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. <a target="_blank" href="http://jco.ascopubs.org/content/29/34/4548.long">J Clin Oncol. 2011 Dec 1;29(34):4548-54</a>.</p><p></p>
                                    </div>
                                    <!--/.seminal-article-body-container -->
                                </section>
                                <!-- /.seminal-article-body -->
                            </div>
                            <!-- ./item-content-section -->
                        </div>
                        <!-- ./item-content -->
                    </div>
                    <!-- /.item-conten-container -->
                    <hr />
                    <footer class="copyright item-footer">
                        <img class="logo" src="content/img/feed/imng_logo.gif" alt="IMNG Medical Media"
                        />
                        <p>
                            Copyright &copy; 2012 Elsevier
                        </p>
                    </footer>
            </div>
            <!--/.item-container-->
            <div class="recommended">
                <div class="recent">
                </div>
                <!--/.recent-->
                <div class="ad">
                    <img src="http://placehold.it/300x250" align="ad" title="ad" />
                </div>
            </div>
            <!--/.recommended-->
        </section>
        <!--/[role="main"]-->
        <section id="sidebar" role="complementary">
            <div class="dashboard">
                <div class="panel cta register">
                    <p>
                        <!-- Meet Our Experts -->
                        Become a member to customize this page.
                        <p>
                            <a class="button" href="#action-register">Register for free</a>
                </div>
                <!--/.panel.cta.register-->
                <div class="component user-console">
                </div>
                <!--/.component.user-console-->
                <div class="component user-topic">
                </div>
                <!--/.component.user-topic-->
                <div class="component topic-spotlight">
                </div>
                <!--/.component.topic-spotlight-->
                <div class="panel">
                    <img src="http://placehold.it/200x200" />
                    <p>
                        <!-- Meet Our Experts -->
                        Meet our Advisory and Editorial Boards comprised of physician editors
                        and world-renowned experts.
                        <p>
                </div>
            </div>
            <!--/.sidebar-->
        </section>
        <!--/.[role="complimentary"]-->
    </div>
    <!--/.page-content-->
    <footer class="page-footer">
    </footer>
    <!-- /.page-footer -->
    <!-- Included JS Files (Uncompressed) -->
    <script src="assets/js/foundation/jquery.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.accordion.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.alerts.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.buttons.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.forms.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.mediaQueryToggle.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.navigation.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.orbit.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.reveal.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tabs.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tooltips.js">
    </script>
    <script src="assets/js/foundation/jquery.placeholder.js">
    </script>
    <script src="assets/js/foundation/app.js">
    </script>
    <script src="assets/js/foundation/jquery.offcanvas.js">
    </script>
    <script src="assets/js/mustache.js">
    </script>
    <!-- Mustache - homepage feed template -->
    <script>
                    	<!--
	Mustache - homepage feed template -->
	$.getJSON('content/json/feed.json', function(data) {
	    $.get('assets/mustache/feed-item.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.stream-container').html(html);
	    });

	});

	<!--
	Mustache - homepage recent template -->
	$.getJSON('content/json/recent.json', function(data) {
	    $.get('assets/mustache/recent.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.recent').html(html);
	    });

	});

	<!--
	Mustache - homepage user - console template -->
	$.getJSON('content/json/user-console.json', function(data) {
	    $.get('assets/mustache/user-console.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-console').html(html);
	    });
	});

	<!--
	Mustache - homepage user - topic template -->
	$.getJSON('content/json/user-topic.json', function(data) {
	    $.get('assets/mustache/user-topic.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-topic').html(html);
	    });
	});

	<!--
	Mustache - homepage topic - spotlight template -->
	$.getJSON('content/json/topic-spotlight.json', function(data) {
	    $.get('assets/mustache/topic-spotlight.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.topic-spotlight').html(html);
	    });
	});
</script>
</body>

</html>